Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors (Q64384951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

S Perachon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J C Schwartz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Sokoloff

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

293-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Treatment of parkinsonism with bromocriptine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Effects of three dopamine agonists on cage climbing behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

The two-state model of receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Distribution of D5 dopamine receptor mRNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Pergolide in the treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Production of climbing behaviour in mice requires both D1 and D2 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

D3 dopamine receptor mRNA is widely expressed in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900896-6

10.1016/S0014-2999(98)00896-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10082211%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference